U.S. Mortgage Finance Stock News

NasdaqCM:CXDO
NasdaqCM:CXDOIT

High Growth Tech Stocks to Watch in the US May 2026

The United States market has shown a robust performance, climbing 3.2% in the last week and up 31% over the past year, with earnings forecasted to grow by 16% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and scalability to capitalize on these favorable market conditions.
NYSE:WAT
NYSE:WATLife Sciences

Identifying May 2026 Stocks Trading Below Estimated Value

The United States market has shown robust growth, with a 3.2% increase over the past week and a remarkable 31% rise over the last year, while earnings are anticipated to grow by 16% annually. In this environment, identifying stocks that are trading below their estimated value can offer investors potential opportunities for gains amidst overall market optimism.
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

May 2026's Top Insider Picks For Growth Companies

The United States market has recently experienced a notable upswing, climbing 3.2% in the last week and an impressive 31% over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership are particularly attractive as they often indicate strong confidence from those closest to the business, aligning well with current market momentum.
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

May 2026's Standout Penny Stocks To Watch

The market has climbed 3.2% in the last 7 days and is up 31% over the last 12 months, with earnings forecast to grow by 16% annually. For those looking to invest in smaller or newer companies, penny stocks — despite their somewhat outdated name — can still offer surprising value. In this article, we highlight several penny stocks that demonstrate financial strength and have the potential for long-term growth.
NasdaqGS:FFBC
NasdaqGS:FFBCBanks

Top Dividend Stocks To Consider In May 2026

The United States market has shown robust growth, climbing 3.2% in the past week and an impressive 31% over the last year, with earnings projected to grow by 16% annually. In such a dynamic environment, dividend stocks that offer both reliable income and potential for capital appreciation can be particularly appealing to investors seeking stability amidst market fluctuations.
NasdaqCM:CELC
NasdaqCM:CELCBiotechs

Is It Too Late To Consider Celcuity (CELC) After Its Recent Share Price Surge?

If you are wondering whether Celcuity at US$139.44 still offers value after its run, the key question is how its fundamentals stack up against that price. The stock has moved sharply in recent periods, with returns of 17.2% over 7 days, 22.1% over 30 days, 38.7% year to date, and a very large 1 year gain accompanied by a 3 year return of 13x and a 5 year return of 4x. These moves sit against a backdrop of ongoing interest in Celcuity's role in the pharmaceuticals and biotech space. In this...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

Exelixis (EXEL) Margin Expansion To 35.1% Challenges Bearish Pricing Narratives

Exelixis (EXEL) opened 2026 with Q1 revenue of US$610.8 million and basic EPS of US$0.81, setting a clear marker for how the year is starting to shape up. The company has seen quarterly revenue move from US$555.4 million in Q1 2025 to US$610.8 million in Q1 2026, while basic EPS over that same span shifted from US$0.57 to US$0.81. This is prompting investors to focus on how sustained profitability and margins might influence sentiment around the latest numbers. See our full analysis for...
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

US Stock Market Today S&P 500 Futures Edge Higher As Rate Relief Hopes Build

The Morning Bull - US Market Morning Update Thursday, May, 7 2026 E-mini S&P 500 futures are a touch higher this morning, as investors weigh easing tensions in the Middle East against fresh signs of a mixed global economy. Hopes for progress in US Iran talks have pushed oil prices lower and pulled the US 10 year Treasury yield down to around 4.35%, which can ease borrowing costs for households and companies. At the same time, US private employers added 109,000 jobs in April, the strongest...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Protagonist Therapeutics Q1 Profit Challenges Trailing Loss Narrative For PTGX Investors

Protagonist Therapeutics (PTGX) opened 2026 with Q1 revenue of US$56.4 million, Basic EPS of US$0.06 and net income of US$3.8 million, while trailing 12 month figures show revenue of US$74.1 million, a Basic EPS loss of US$1.79 and a net loss of US$114.7 million. Over the past year, the company has seen quarterly revenue move between US$4.7 million and US$170.6 million, alongside Basic EPS that has ranged from a US$2.11 profit to a US$0.69 loss. These figures give investors a broad set of...
NasdaqGS:POWL
NasdaqGS:POWLElectrical

Is It Too Late To Consider Powell Industries (POWL) After Its Surging Share Price?

If you are wondering whether Powell Industries at around US$320 per share still offers value, it helps to separate headline returns from what the underlying valuation is actually saying. The stock has posted very strong returns, with gains of 26.4% over the last week, 71.5% over the past month, 172.6% year to date and 451.6% over the last year, plus a multi year return of more than 17x. Recent coverage has focused on Powell Industries as part of broader discussions around power...
NasdaqGS:VECO
NasdaqGS:VECOSemiconductor

Veeco Instruments (VECO) Margin Compression And Q1 Loss Test Bullish Growth Narratives

Veeco Instruments (VECO) opened 2026 with Q1 revenue of US$158.3 million, basic EPS of roughly a US$0.01 loss, and trailing 12‑month EPS of US$0.39 on US$655.3 million of revenue, setting up a quarter where profitability was in focus. The company has seen quarterly revenue move from US$167.3 million and basic EPS of US$0.21 in Q1 2025 to US$158.3 million and a small loss in Q1 2026, while trailing 12‑month EPS moved from US$1.31 on US$717.3 million of revenue at Q4 2024 to US$0.39 on US$655.3...